Fidelity Advisor Biotechnology Fund Investor Sentiment

FBTTX Fund  USD 24.94  0.22  0.89%   
Slightly above 51% of Fidelity Advisor's investor base is interested to short. The analysis of overall sentiment of trading Fidelity Advisor Biotechnology mutual fund suggests that many investors are impartial at this time. Fidelity Advisor's investing sentiment can be driven by a variety of factors including economic data, Fidelity Advisor's earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
BlackRock funds are crushing shareholder rights, says activist Boaz Weinstein - CNBC
Google News at Macroaxis
over a year ago at news.google.com         
White House bashes GOP plan to shift funds from Gaza aid to Israel Iron Dome Not Hamas - Fox News
Google News at Macroaxis
20 hours ago at finance.yahoo.com         
Should You Invest in the Invesco Biotechnology Genome ETF?
Yahoo News
3 days ago at gurufocus.com         
Incyte Corp Announces Positive Phase 3 Trial Results for Povorcitinib in Treating ...
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance DelveInsigh...
Yahoo News
few days ago at finance.yahoo.com         
HUTCHMED and Innovent Jointly Announce that the FRUSICA-2 PhaseIIIII Study of Fruquintinib and Sinti...
Yahoo News
few days ago at businesswire.com         
Resumen Incyte anunci resultados positivos de datos principales en dos ensayos clnicos de fase 3 sob...
businesswire News
few days ago at seekingalpha.com         
Incyte downgraded to Neutral at Guggenheim on trial results for skin disease treatment
seekingalpha News
six days ago at finance.yahoo.com         
Why Incyte Stock Is Nosediving
Yahoo News
six days ago at finance.yahoo.com         
Incyte Leads SP 500 Decliners on Skin Condition Drug Trial Results
Yahoo News
six days ago at investors.com         
Incyte Plummets 13 percent As Skin Disease Drug Looks Viable, But Not Competitive
Investors Business Daily at Macroaxis
over a week ago at finance.yahoo.com         
Disposition of 19147 shares by Flannelly Barry P of Incyte at 67.68 subject to Rule 16b-3
Yahoo News
a minute ago at thelincolnianonline.com         
Mascoma Wealth Management LLC Buys 1 Shares of Gilead Sciences, Inc.
news
a day ago at thelincolnianonline.com         
Plancorp LLC Has 559,000 Stock Holdings in Gilead Sciences, Inc.
news
2 days ago at thelincolnianonline.com         
Whittier Trust Co. of Nevada Inc. Trims Holdings in Gilead Sciences, Inc.
news
3 days ago at newsweek.com         
The Handmaids Tale Season 6 Release Date, Schedule, How To Watch
news
few days ago at finance.yahoo.com         
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
Yahoo News
few days ago at investors.com         
ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings Move. Heres Why.
Investors Business Daily at Macroaxis
few days ago at upi.com         
Elisabeth Moss takes on Gilead in Handmaids Tale Season 6 trailer
news
few days ago at newswire.com         
Gilead Sciences Ranked in Top Five Most JUST List for Biopharma Companies
news
six days ago at insidermonkey.com         
Is Gilead Sciences, Inc. a Best Biotech Stock According to Billionaires?
insidermonkey News
over a week ago at thelincolnianonline.com         
Greenwich Wealth Management LLC Decreases Position in Gilead Sciences, Inc.
news
a minute ago at finance.yahoo.com         
Ionis Pharmaceuticals Down 2.8 percent Since Last Earnings Report Can It Rebound?
Yahoo News
3 days ago at finance.yahoo.com         
Why Is Ionis Pharmaceuticals Up 0.1 percent Since Last Earnings Report?
Yahoo News
few days ago at thelincolnianonline.com         
Tocqueville Asset Management L.P. Has 12.31 Million Stake in Ionis Pharmaceuticals, Inc.
news
over a week ago at businesswire.com         
Oligonucleotide Therapeutics Market Analysis and Forecast 2025-2035 Focus on Oncology, Infectious Di...
businesswire News
over a week ago at finance.yahoo.com         
Acquisition by Elizabeth Hougen of 23887 shares of Ionis Pharmaceuticals subject to Rule 16b-3
Yahoo News
over a week ago at businesswire.com         
WAINZUA approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adu...
businesswire News
over two weeks ago at kalkinemedia.com         
How Is Ionis Pharmaceuticals Expanding Its RNA-Targeted Therapeutics Portfolio?
news
over three weeks ago at www.macroaxis.com         
Acquisition by Bennett C Frank of 320 shares of Ionis Pharmaceuticals at 28.2115 subject to Rule 16b...
Macroaxis News
over three weeks ago at thelincolnianonline.com         
Ionis Pharmaceuticals, Inc. EVP Patrick R. Oneil Sells 1,207 Shares
news
over three weeks ago at finance.yahoo.com         
Global Amyloidosis Therapeutics Market Outlook to Exceed US 6.3 Billion by 2035 at 8.2 percent CAGR,...
Yahoo News
a minute ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Vertex Q4 Earnings
Yahoo News
a day ago at finance.yahoo.com         
Jim Cramer on Vertex A Revolutionary Anti-Pain Drug
Yahoo News
3 days ago at finance.yahoo.com         
Acquisition by Altshuler David of 7114 shares of Vertex Pharmaceuticals subject to Rule 16b-3
Yahoo News
3 days ago at benzinga.com         
100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
benzinga news
few days ago at thelincolnianonline.com         
Vertex Pharmaceuticals Incorporated Shares Bought by Royal London Asset Management Ltd.
news
few days ago at finance.yahoo.com         
CABLIVI Market Reports Positive Growth - Strong Momentum Expected to Continue DelveInsight
Yahoo News
few days ago at finance.yahoo.com         
GOOGL to Buy Wiz for 32B Smart Move for the Stock or a Risky Bet?
Yahoo News
few days ago at finance.yahoo.com         
Disposition of 2143 shares by Ourania Tatsis of Vertex Pharmaceuticals at 467.98 subject to Rule 16b...
Yahoo News
few days ago at finance.yahoo.com         
CRISPR Therapeutics Among Top Stocks to Buy from Ark Invests Portfolio
Yahoo News
few days ago at insidermonkey.com         
Vertex Pharmaceuticals One of the Best Biotech Stocks to Buy According to Billionaires
insidermonkey News
a minute ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Janney Montgomery Scott LLC
news
a minute ago at thelincolnianonline.com         
Silver Oak Securities Incorporated Boosts Holdings in AbbVie Inc.
news
a day ago at finance.yahoo.com         
Is AbbVie Inc. The Best Healthcare Dividend Stock to Invest in?
Yahoo News
3 days ago at thelincolnianonline.com         
AbbVie Shares Down 0.7 percent Should You Sell?
news
few days ago at fool.com         
Heres How Many Shares of AbbVie You Need to Own to Get 1,000 in Yearly Dividends
fool News
few days ago at thelincolnianonline.com         
AbbVie Trading Down 0.2 percent Time to Sell?
news
few days ago at talkmarkets.com         
Elliott Wave Technical Analysis AbbVie Inc. - Wednesday, March 19
news
few days ago at finance.yahoo.com         
Antibody Drug Conjugates Contract Manufacturing Market Research Report 2025 Growth Trends and Region...
Yahoo News
few days ago at zacks.com         
Disposition of 14973 shares by Timothy Richmond of AbbVie at 210.66 subject to Rule 16b-3
zacks News
six days ago at thelincolnianonline.com         
1ST Source Bank Sells 219 Shares of AbbVie Inc.
news
3 days ago at thelincolnianonline.com         
TG Therapeutics Reaches New 12-Month High Should You Buy?
news
few days ago at insidermonkey.com         
TG Therapeutics Among the Best Short Squeeze Stocks to Buy According to Analysts
insidermonkey News
over a week ago at finance.yahoo.com         
Is TG Therapeutics, Inc. the Best Performing Growth Stock in 2025?
Yahoo News
over a week ago at investors.com         
IBD Live QA And Two Key Stock Lists For March 11, 2025
Investors Business Daily at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 6000 shares by Charney Laurence N of TG Therapeutics subject to Rule 16b-3
Macroaxis News
over two weeks ago at gurufocus.com         
TGTX Surges on Strong Q4 Results and Briumvi Success
Gurufocus Stories at Macroaxis
over two weeks ago at globenewswire.com         
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI in Multiple Sclerosis at the Am...
Macroaxis News: globenewswire.com
over two weeks ago at finance.yahoo.com         
Why TG Therapeutics, Inc. Surged On Monday?
Yahoo News
over two weeks ago at gurufocus.com         
TG Therapeutics Inc Q4 2024 Earnings Call Highlights Strong U.S. ...
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
TG Therapeutics Soars Nearly 18 percent as Strong Q4 Results Fuel Growth Optimism
Yahoo News
20 hours ago at finance.yahoo.com         
Biogen plots new global headquarters in Kendall Square
Yahoo News
2 days ago at www.macroaxis.com         
Disposition of 296 shares by Rothfuss Cristin of Sarepta Therapeutics at 101.34 subject to Rule 16b-...
Macroaxis News
3 days ago at thelincolnianonline.com         
Top Mid Cap Stocks To Follow Today March 18th
news
few days ago at finance.yahoo.com         
Strength Seen in Sarepta Therapeutics Can Its 8.7 percent Jump Turn into More Strength?
Yahoo News
few days ago at zacks.com         
Biotech Stock Roundup Patient Death Hits SRPT, INCY Study Data More
zacks News
few days ago at finance.yahoo.com         
Why Sarepta Therapeutics Inc. Crashed On Tuesday?
Yahoo News
few days ago at bizjournals.com         
Duchenne patient on Sareptas gene therapy dies
bizjournals News
few days ago at thelincolnianonline.com         
Medical Stocks To Follow Today March 18th
news
over a week ago at thelincolnianonline.com         
Claude Nicaise Sells 2,491 Shares of Sarepta Therapeutics, Inc. Stock
news
over a week ago at kalkinemedia.com         
How Is Sarepta Therapeutics Strengthening Its Market Position?
news
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over a year ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
a minute ago at zacks.com         
Regeneron Q4 Earnings and Revenues Beat Estimates
zacks News
2 days ago at thelincolnianonline.com         
Alnylam Pharmaceuticals Given New 338.00 Price Target at Scotiabank
news
3 days ago at thelincolnianonline.com         
Advisors Asset Management Inc. Sells 443 Shares of Regeneron Pharmaceuticals, Inc.
news
few days ago at thelincolnianonline.com         
Avantax Advisory Services Inc. Purchases 404 Shares of Regeneron Pharmaceuticals, Inc.
news
few days ago at finance.yahoo.com         
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update...
Yahoo News
few days ago at thelincolnianonline.com         
Cibc World Markets Corp Acquires 2,201 Shares of Regeneron Pharmaceuticals, Inc.
news
few days ago at finance.yahoo.com         
Fabhalta Shakes Up the PNH Market in 15 Months as Soliris, Ultomiris, and Empaveli Compete and Voyde...
Yahoo News
six days ago at finance.yahoo.com         
Oncology Market Assessment Strategic Insights for Investment or Divestment DelveInsight
Yahoo News
over a week ago at thelincolnianonline.com         
Greykasell Wealth Strategies Inc. Makes New 504,000 Investment in Regeneron Pharmaceuticals, Inc.
news
over a week ago at finance.yahoo.com         
Weekly Roundup 15 Tech Press Releases You Need to See
Yahoo News
3 days ago at gurufocus.com         
Insider Sell William Waddill Sells 4,000 Shares of Protagonist Therapeutics Inc
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Analysts Mentions Growth Catalysts for Protagonist Therapeutics Best Biotech Stock for 2025?
Yahoo News
over a week ago at finance.yahoo.com         
The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and JJ
Yahoo News
over a week ago at zacks.com         
Protagonist Therapeutics Upgraded to Buy Heres Why
zacks News
over a week ago at finance.yahoo.com         
Why Protagonist Therapeutics, Inc. Went Up on Monday
Yahoo News
over a week ago at finance.yahoo.com         
PTGX Up as JJ-Partnered Drug Meets Goal in Ulcerative Colitis Study
Yahoo News
over two weeks ago at gurufocus.com         
Protagonist Therapeutics Inc Announces Promising Phase 3 Results for Icotrokinra in ...
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Protagonist Therapeutics Given New 57.00 Price Target at JPMorgan Chase Co.
news
over three weeks ago at www.macroaxis.com         
Disposition of 24000 shares by Dinesh Patel of Protagonist Therapeutics at 4.21 subject to Rule 16b-...
Macroaxis News
over three weeks ago at kalkinemedia.com         
Can This Biopharma Innovator Revolutionize Blood Disorder Treatment?
news
few days ago at zacks.com         
Novavax Stock Dips While Market Gains Key Facts
zacks News
six days ago at finance.yahoo.com         
Investors Heavily Search Novavax, Inc. Here is What You Need to Know
Yahoo News
over a week ago at simplywall.st         
Acquisition by Shiver John W. of 23840 shares of Novavax subject to Rule 16b-3
Simply Wall St News at Macroaxis
over a week ago at abcnews.go.com         
5 years ago, the WHO declared COVID a pandemic. Heres a look at the disease by the numbers
news
over two weeks ago at www.macroaxis.com         
Disposition of 1107 shares by Young James F of Novavax at 14.28 subject to Rule 16b-3
Macroaxis News
over two weeks ago at finance.yahoo.com         
Disposition of 5375 shares by Ohara Elaine of Novavax at 8.33 subject to Rule 16b-3
Yahoo News
over two weeks ago at finance.yahoo.com         
Here is What to Know Beyond Why Novavax, Inc. is a Trending Stock
Yahoo News
over three weeks ago at finance.yahoo.com         
Novavax, Inc. Shares Could Be 45 percent Below Their Intrinsic Value Estimate
Yahoo News
over three weeks ago at gurufocus.com         
Decoding Novavax Inc A Strategic SWOT Insight
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Q4 2024 Novavax Inc Earnings Call Transcript
Gurufocus Stories at Macroaxis
a minute ago at finance.yahoo.com         
Neurocrines Phase II schizophrenia trial fails to meet primary endpoint
Yahoo News
3 days ago at gurufocus.com         
Neurocrine Biosciences Inc Reports Promising 48-Week Remission Data for Tardive ...
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Primecap Management Co. CA Sells 10,290 Shares of Neurocrine Biosciences, Inc.
news
over a week ago at thelincolnianonline.com         
Neurocrine Biosciences, Inc. Shares Sold by AlphaQuest LLC
news
over a week ago at finance.yahoo.com         
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
Yahoo News
over a week ago at finance.yahoo.com         
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
Yahoo News
over two weeks ago at thelincolnianonline.com         
Acquisition by Roberts Eiry of 2113 shares of Neurocrine Biosciences subject to Rule 16b-3
news
over two weeks ago at finance.yahoo.com         
Disposition of 1352 shares by Abernethy Matt of Neurocrine Biosciences at 116.8487 subject to Rule 1...
Yahoo News
over two weeks ago at gurufocus.com         
Neurocrine Biosciences Initiates Phase 1 Clinical Study for New VMAT2 Inhibitor
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
GWK Investment Management LLC Grows Holdings in Neurocrine Biosciences, Inc.
news
20 hours ago at investors.com         
Biotech Leader Exelixis Eyes Buy Point In Todays Stock Market Rally
Investors Business Daily at Macroaxis
3 days ago at finance.yahoo.com         
Exact Sciences Down 10.6 percent Since Last Earnings Report Can It Rebound?
Yahoo News
few days ago at finance.yahoo.com         
Exelixis Growth Continues with Big Money Boosts
Yahoo News
few days ago at thelincolnianonline.com         
Skandinaviska Enskilda Banken AB publ Takes 425,000 Position in Exelixis, Inc.
news
over a week ago at zacks.com         
Exelixis Up 13.4 percent Since Last Earnings Report Can It Continue?
zacks News
over a week ago at zacks.com         
Are You a Momentum Investor This 1 Stock Could Be the Perfect Pick
zacks News
over a week ago at thelincolnianonline.com         
Essex Investment Management Co. LLC Sells 1,649 Shares of Exelixis, Inc.
news
over two weeks ago at www.macroaxis.com         
Acquisition by Christopher Senner of 29314 shares of Exelixis at 18.8 subject to Rule 16b-3
Macroaxis News
over two weeks ago at globenewswire.com         
AXL Inhibitors Pipeline Research Report 2025 Features Insights on 16 Companies and 20 Pipeline Drugs...
Macroaxis News: globenewswire.com
over two weeks ago at thelincolnianonline.com         
Grandfield Dodd LLC Has 728,000 Stock Holdings in Exelixis, Inc.
news
3 days ago at thelincolnianonline.com         
Agios Pharmaceuticals, Inc. Given Consensus Rating of Moderate Buy by Analysts
news
over a week ago at finance.yahoo.com         
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
Yahoo News
over two weeks ago at thelincolnianonline.com         
Brokers Set Expectations for AGIO FY2027 Earnings
news
over two weeks ago at gurufocus.com         
Insider Trading
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Disposition of 4153 shares by Goff Brian of Agios Pharm at 35.54 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
Is Agios Pharmaceuticals, Inc. the Best Small-Cap Stock to Buy Now?
Yahoo News
over three weeks ago at kalkinemedia.com         
What Is Driving Recent Moves in Agios Pharmaceuticals?
news
over a month ago at simplywall.st         
Why Agios Pharmaceuticals Earnings Are Weaker Than They Seem
Simply Wall St News at Macroaxis
over a month ago at insidermonkey.com         
Agios Pharmaceuticals, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over a month ago at finance.yahoo.com         
Agios Pharmaceuticals Inc Q4 2024 Earnings Call Highlights Robust Revenue Growth and ...
Yahoo News
20 hours ago at upi.com         
FDA approves new drug to treat protein buildup in the heart
news
2 days ago at thelincolnianonline.com         
Cibc World Markets Corp Has 1.37 Million Stock Position in Alnylam Pharmaceuticals, Inc.
news
3 days ago at investors.com         
Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio
Investors Business Daily at Macroaxis
few days ago at bizjournals.com         
Alnylam wins FDA approval for rare heart disease drug
bizjournals News
few days ago at thelincolnianonline.com         
Royal London Asset Management Ltd. Increases Stock Holdings in Alnylam Pharmaceuticals, Inc.
news
few days ago at finance.yahoo.com         
Arbor raises 74M amid genetic medicines funding slump
Yahoo News
over a week ago at thelincolnianonline.com         
Acquisition by Schulman Amy W of 2750 shares of Alnylam Pharmaceuticals at 131.21 subject to Rule 16...
news
over a week ago at thelincolnianonline.com         
StockNews.com Upgrades Alnylam Pharmaceuticals to Buy
news
over a week ago at finance.yahoo.com         
Shift Bioscience Announces Key Appointments to Advance Rejuvenation Therapeutics Pipeline
Yahoo News
over a week ago at finance.yahoo.com         
3 High Growth Tech Stocks To Watch In The US Market
Yahoo News
a minute ago at businesswire.com         
AstraZenecas Full Year and Q4 2024 results
businesswire News
a day ago at insidermonkey.com         
Is Amgen Inc. The Best Healthcare Dividend Stock to Invest in?
insidermonkey News
2 days ago at thelincolnianonline.com         
Promising Healthcare Stocks To Follow Now March 22nd
news
3 days ago at finance.yahoo.com         
Why Amgen is a Top Value Stock for the Long-Term
Yahoo News
few days ago at thelincolnianonline.com         
Amgen Inc. Holdings Lifted by Trillium Asset Management LLC
news
few days ago at finance.yahoo.com         
Verastem Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent ...
Yahoo News
few days ago at thelincolnianonline.com         
Cozad Asset Management Inc. Buys 100 Shares of Amgen Inc.
news
few days ago at news.mit.edu         
At the core of problem-solving
news
few days ago at thelincolnianonline.com         
Intech Investment Management LLC Has 15.79 Million Holdings in Amgen Inc.
news
few days ago at zacks.com         
Why the Market Dipped But Amgen Gained Today
zacks News
a day ago at thelincolnianonline.com         
Simplify Asset Management Inc. Reduces Stake in argenx SE
news
six days ago at thelincolnianonline.com         
argenx Upgraded to Outperform at Sanford C. Bernstein
news
over a week ago at zacks.com         
EXEL vs. ARGX Which Stock Should Value Investors Buy Now?
zacks News
over two weeks ago at gurufocus.com         
argenx SE Announces Promising Data for VYVGART at AAN Annual Meeting
Gurufocus Stories at Macroaxis
over two weeks ago at kalkinemedia.com         
Is argenx SE Expanding Its Role in the Biotechnology Sector?
news
over three weeks ago at thelincolnianonline.com         
Dynasty Wealth Management LLC Acquires 22 Shares of argenx SE
news
over three weeks ago at zacks.com         
Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus
zacks News
over three weeks ago at zacks.com         
CORTs Q4 Earnings and Revenues Fall Short of Estimates
zacks News
over three weeks ago at gurufocus.com         
argenx to Present at TD Cowen 45th Annual Healthcare Conference
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
argenx SE Announces Upcoming Conference Call for 2024 Financial Results
Gurufocus Stories at Macroaxis
3 days ago at news.google.com         
Biotech designed to commercialize Ascendis endocrinology drugs in China files 86M IPO - FiercePharma
Google News at Macroaxis
few days ago at finance.yahoo.com         
Ascendis Pharma Soars 10.4 percent Is Further Upside Left in the Stock?
Yahoo News
over a week ago at news.google.com         
Ascendis Pharma Grants Employee Warrants to Strengthen Retention - TipRanks
Google News at Macroaxis
over two weeks ago at gurufocus.com         
Avoro Capital Advisors LLC Increases Stake in Aadi Bioscience Inc
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
Ascendis Pharma AS Shares Sold by Handelsbanken Fonder AB
news
over three weeks ago at gurufocus.com         
Ascendis Pharma to Participate in theTD Cowen 45th Annual Healt
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Q1 EPS Forecast for Ascendis Pharma AS Decreased by Analyst
news
over a month ago at finance.yahoo.com         
High Growth Tech Stocks And 2 More High Potential Picks
Yahoo News
over a month ago at finance.yahoo.com         
Ascendis Pharma AS Just Reported Annual Earnings Have Analysts Changed Their Mind On The Stock?
Yahoo News
over a month ago at gurufocus.com         
JANUS HENDERSON GROUP PLC Expands Stake in Ascendis Pharma AS
Gurufocus Stories at Macroaxis
20 hours ago at finance.yahoo.com         
Q4 Rundown Moderna Vs Other Therapeutics Stocks
Yahoo News
3 days ago at finance.yahoo.com         
BioMarin Up 4.2 percent Since Last Earnings Report Can It Continue?
Yahoo News
few days ago at finance.yahoo.com         
BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinica...
Yahoo News
few days ago at insidermonkey.com         
BioMarin Pharmaceutical Among Paul Singers Latest Portfolios Top Stock Picks
insidermonkey News
few days ago at insidermonkey.com         
Is BioMarin Pharmaceutical the Best Biotech Stock According to Billionaires?
insidermonkey News
few days ago at zacks.com         
INCY Stock Down on Disappointing Skin Disease Study Data
zacks News
six days ago at zacks.com         
Heres Why BioMarin Pharmaceutical is a Strong Growth Stock
zacks News
over a week ago at thelincolnianonline.com         
AGF Management Ltd. Sells 1,194,524 Shares of BioMarin Pharmaceutical Inc.
news
over a week ago at thelincolnianonline.com         
BioMarin Pharmaceutical Inc. Shares Purchased by AlphaQuest LLC
news
over a week ago at zacks.com         
Why BioMarin Pharmaceutical is a Top Momentum Stock for the Long-Term
zacks News
a minute ago at seekingalpha.com         
Ascent Industries sells Bristol Metals for 45M
seekingalpha News
a day ago at bbc.co.uk         
Bristol A4 Portway closed in both directions due to police incident
news
2 days ago at finance.yahoo.com         
Is Bristol-Myers Squibb Among the Cheap Stocks to Buy According to Billionaires?
Yahoo News
3 days ago at insidermonkey.com         
Bristol-Myers Squibb Company Among Incredibly Cheap Dividend Stock to Buy Now
insidermonkey News
few days ago at insidermonkey.com         
Is Bristol-Myers Squibb Company The Best Undervalued Stock to Buy According to Billionaires?
insidermonkey News
few days ago at bbc.co.uk         
Drivers told to avoid M4 near Bristol during bridge demolition
news
few days ago at finance.yahoo.com         
Molecular Glues Market to Register Stunning Growth During the Forecast Period DelveInsight
Yahoo News
few days ago at finance.yahoo.com         
Bristol Myers Squibb Ascends But Remains Behind Market Some Facts to Note
Yahoo News
few days ago at thelincolnianonline.com         
Xponance Inc. Acquires 11,370 Shares of Bristol-Myers Squibb
news
few days ago at aol.com         
Premiership to trial separate away sections for fans in upcoming fixtures
news
a minute ago at benzinga.com         
IonQ, HE Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week Are The Others I...
benzinga news
few days ago at kalkinemedia.com         
Is Blueprint Medicines Gaining Momentum in the Biotechnology Sector?
news
over a week ago at news.google.com         
Disposition of 1800 shares by Albers Jeffrey W. of Blueprint Medicines at 88.37 subject to Rule 16b-...
Google News at Macroaxis
over a week ago at news.google.com         
Blueprint Medicines Co. Stock Holdings Lifted by Bank of New York Mellon Corp - Defense World
Google News at Macroaxis
over two weeks ago at simplywall.st         
Is Blueprint Medicines A Risky Investment?
Simply Wall St News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 2541 shares by Hewes L. Becker of Blueprint Medicines at 87.98 subject to Rule 16b-3
Macroaxis News
over two weeks ago at thelincolnianonline.com         
Disposition of 1075 shares by Ariel Hurley of Blueprint Medicines at 95.16 subject to Rule 16b-3
news
over two weeks ago at www.macroaxis.com         
Acquisition by Haviland Kate of 70400 shares of Blueprint Medicines at 96.57 subject to Rule 16b-3
Macroaxis News
over three weeks ago at finance.yahoo.com         
Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI WAO J...
Yahoo News
over three weeks ago at finance.yahoo.com         
Blueprint Medicines Corporation Among the Oversold Biotech Stocks to Buy Now
Yahoo News
20 hours ago at finance.yahoo.com         
Cytokinetics Moves 5.4 percent Higher Will This Strength Last?
Yahoo News
3 days ago at gurufocus.com         
Cytokinetics Inc Announces Stock Option Grants to New Employees
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic ...
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635
Gurufocus Stories at Macroaxis
six days ago at finance.yahoo.com         
Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Se...
Yahoo News
over a week ago at news.google.com         
Cytokinetics Nears Approval Buy The New Potential Cardiology Franchise With Aficamten - Seeking Alph...
Google News at Macroaxis
over a week ago at statnews.com         
The essential biotech news stories of the day
news
over two weeks ago at gurufocus.com         
Insider Sell Alert Fady Malik Sells Shares of Cytokinetics Inc
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Revenue Downgrade Heres What Analysts Forecast For Cytokinetics, Incorporated
Yahoo News
over two weeks ago at gurufocus.com         
Insider Sell Alert Fady Malik Sells 2,000 Shares of Cytokinetics Inc
Gurufocus Stories at Macroaxis
20 hours ago at news.google.com         
Fibrogen director James Schoeneck buys 105,040 in stock By Investing.com - Investing.com Canada
Google News at Macroaxis
few days ago at finance.yahoo.com         
FibroGen Full Year 2024 Earnings Beats Expectations
Yahoo News
few days ago at gurufocus.com         
Q4 2024 FibroGen Inc Earnings Call Transcript
Gurufocus Stories at Macroaxis
six days ago at finance.yahoo.com         
FibroGen Q4 Earnings Snapshot
Yahoo News
over a week ago at finance.yahoo.com         
Akebia Therapeutics Reports Q4 Loss, Tops Revenue Estimates
Yahoo News
over three weeks ago at finance.yahoo.com         
Aurinia Pharmaceuticals Beats Q4 Earnings and Revenue Estimates
Yahoo News
over three weeks ago at benzinga.com         
Acquisition by Brennan Aoife of 70000 shares of FibroGen at 1.21 subject to Rule 16b-3
benzinga news
over three weeks ago at Macroaxis         
Will Ardelyx (USA Stocks:ARDX) shadow FibroGen price jump?
Macroaxis News
over three weeks ago at thelincolnianonline.com         
Penny Stocks To Follow Now February 20th
news
over a month ago at finance.yahoo.com         
AstraZeneca deepens China presence with FibroGen deal
Yahoo News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at thelincolnianonline.com         
Vinva Investment Management Ltd Purchases New Position in Biogen Inc.
news
few days ago at zacks.com         
Axsome Down 0.8 percent Since Last Earnings Report Can It Rebound?
zacks News
few days ago at finance.yahoo.com         
Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the...
Yahoo News
few days ago at insidermonkey.com         
Biogen Inc. Among the Most Undervalued Biotech Stocks to Invest In
insidermonkey News
few days ago at finance.yahoo.com         
Stoke Therapeutics Stock Slips as CEO Steps Down
Yahoo News
few days ago at finance.yahoo.com         
Rare Neurological Disease Treatment Market to Reach USD 115.8 Billion by 2035, Growing at 9.7 percen...
Yahoo News
six days ago at businesswire.com         
SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General Kahn Swick Foti, LLC ...
businesswire News
six days ago at businesswire.com         
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financ...
businesswire News
over a week ago at zacks.com         
Why Is Biogen Up 1.1 percent Since Last Earnings Report?
zacks News
few days ago at www.macroaxis.com         
Acquisition by Vittiglio Joseph of 50000 shares of Bluebird Bio subject to Rule 16b-3
Macroaxis News
over a week ago at prnewswire.com         
LINGO RELEASES SPACE-THEMED STEM KITS AS FOUNDER PREPARES FOR HISTORIC ALL-FEMALE BLUE ORIGIN FLIGHT
prnewswire News
over a week ago at finance.yahoo.com         
BMS to acquire longtime cell therapy partner 2seventy bio for 286m
Yahoo News
over two weeks ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS AND MASSCHALLENGE ANNOUNCE 2025 HEALTH EQUITY BUSINESS ACCEL...
prnewswire News
over three weeks ago at news.google.com         
bluebird bio stock slides for second day on buyout news - MSN
Google News at Macroaxis
over three weeks ago at prnewswire.com         
MONSTER ENERGY LAUNCHES NEW ZERO SUGAR ULTRA BLUE HAWAIIAN
prnewswire News
over a month ago at seekingalpha.com         
bluebird bio stock on watch after MA deal
seekingalpha News
over a month ago at businesswire.com         
Shareholder Alert Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for it...
businesswire News
over a month ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS ENHANCES DIABETES SUPPORT FOR MEMBERS
prnewswire News
over a month ago at globenewswire.com         
Blue Point Brewing Announces 5th Annual Shakedown on Main Street Festival
Macroaxis News: globenewswire.com
2 days ago at www.macroaxis.com         
Insider Trading
Macroaxis News
six days ago at globenewswire.com         
Acquisition by Barry Greene of 66500 shares of Sage Therapeutic at 45.28 subject to Rule 16b-3
Macroaxis News: globenewswire.com
over a week ago at zacks.com         
Sage Therapeutics Up 7.4 percent Since Last Earnings Report Can It Continue?
zacks News
over two weeks ago at bizjournals.com         
Sages medical chief is latest leader to leave biotech
bizjournals News
over two weeks ago at finance.yahoo.com         
Sage Therapeutics Announces RD Leadership Transition
Yahoo News
over three weeks ago at finance.yahoo.com         
Key Themes, Strategic Moves, and Market Dynamics from JP Morgans 43rd Annual Healthcare Conference, ...
Yahoo News
over three weeks ago at thelincolnianonline.com         
Sage Therapeutics and Phibro Animal Health Head-To-Head Contrast
news
over a month ago at gurufocus.com         
BB Biotech AG Reduces Stake in Agios Pharmaceuticals Inc.
Gurufocus Stories at Macroaxis
over a month ago at insidermonkey.com         
Sage Therapeutics, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over a month ago at finance.yahoo.com         
Less Manual Work, More Financial Control Sage Intacct Further Advances AI for Finance Teams
Yahoo News
Far too much social signal, news, headlines, and media speculation about Fidelity Advisor that are available to investors today. That information is available publicly through Fidelity media outlets and privately through word of mouth or via Fidelity internal channels. However, regardless of the origin, that massive amount of Fidelity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fidelity Advisor news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fidelity Advisor relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fidelity Advisor's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fidelity Advisor alpha.

Other Information on Investing in Fidelity Mutual Fund

Fidelity Advisor financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Advisor security.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio